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Heterosexual transmission through mucosal surfaces is
one of the most common routes of HIV-1 spread. Topical
microbicides are self-applied prophylactic agents, used to
prevent vaginal and other mucosal transmission of HIV-1,
which have the advantage of empowering vulnerable
receptive partners to take effective measures for their own
protection. In a search for candidate topical microbicides
we discovered that retrocyclin, a unique θ-defensin syn-
thetically constructed based on sequence data from its
pseudogene, can potently prevent infection of CD4+ cells
by both X4 and R5 HIV-1. While many studies have uti-
lized simulants of mucosal fluid to test compounds, we
are studying how whole human vaginal fluid and its func-
tional components affect the activity and stability of pep-
tide-based microbicides. We explored a novel,
physiologically relevant approach to assess the ability of a
candidate retrocyclin microbicide, RC-101, to inhibit
HIV-1 infection of immunocompetent human cervicovag-
inal tissue. We revealed that 1) using a novel proteomic
approach, human vaginal fluid contained at least 20 dif-
ferent cationic (poly)peptides with purported roles in
innate host defense, 2) the cationic polypeptide fraction
of vaginal fluid was required for innate anti-HIV-1 activ-
ity, 3) RC-101 retained full anti-HIV-1 activity in the pres-
ence of whole human vaginal fluid, 4) when applied
apically to organotypical cervicovaginal epithelium, RC-
101 was retained in the tissue, and 5) RC-101 prevented
HIV-1 infection of immunocompetent organotypic cervi-
covaginal epithelium. Collectively, we have characterized
the innate antiviral host defense factors within vaginal
fluid, and developed a highly relevant ex vivo vaginal
model suitable for peptide-based microbicide evaluation.
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